-
Maxion Therapeutics Strengthens Board with Appointment of Dr. Santiago Arroyo as a Non-Executive Director
27 Aug 2025 12:00 GMT
… , Bristol Myers Squibb, Eisai and Schwarz Pharma, in positions of increasing responsibility …
-
Satellos Bioscience Shareholders Elect Two New Board Members
18 Jun 2025 21:11 GMT
… R&D roles at Schwarz Pharma, BASF Pharma, and Hoechst…
-
Dopamine Agonists Global Market Trends, Research, and Development - Market Shares, Segments and Insights up to 2034
27 May 2025 11:49 GMT
… . Ltd., AffaMed Therapeutics Holdings Limited, Schwarz Pharma AG.
Order Your Report Now …
-
Maintenance OCS Were Used More Frequently Than Biologics in Patients with Uncontrolled GINA 4/5 Asthma in Germany in 2019
31 Oct 2024 14:46 GMT
… -Hexal, Stallergens, TEVA, UCB/ Schwarz-Pharma, Zydus/Cadila and has … , Sandoz-Hexal, TEVA, UCB/Schwarz-Pharma and has received research grants …
-
National Audubon Society Board of Directors Elects Dr. George Golumbeski as Chairman
01 Oct 2024 19:51 GMT
… Celgene, Novartis, Elan Pharmaceuticals, and Schwarz Pharma. In his free time, he …
-
Cure Rare Disease Expands Leadership Team and Board of Directors to Advance Mission
17 Jun 2024 12:42 GMT
… the Chief Executive Officer of Schwarz Pharma Inc. with responsibility for the …
-
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
02 May 2024 11:16 GMT
… , through his work at Sanofi, Schwarz Pharma, Teva Pharmaceuticals and AstraZeneca, Professor …
-
Women in Science: UCB’s Iris Loew-Friedrich: ‘patients are what get me out of bed every morning’
16 Aug 2023 10:36 GMT
… of research and development at Schwarz Pharma, acquired by UCB in 2006 …
-
Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany
04 Aug 2023 06:06 GMT
… -Hexal, Stallergens, TEVA, UCB/Schwarz-Pharma, and Zydus/Cadila, and … -Hexal, TEVA, and UCB/Schwarz-Pharma, and has received research grants …
-
Effective Management of “OFF” Episodes in Parkinson’s Disease: Emerging Treatment Strategies and Unmet Clinical Needs
25 Jan 2023 13:51 GMT
… of CD/LD (Parcopa®, Schwarz Pharma, Mequon, WI) was FDA approved … . This formulation uses RapiTab™ technology (Schwarz Pharma, Monheim, Germany), which allows the …